Zusammenfassung
Der zeitliche Verlauf der Wiedererlangung der Erektionsfähigkeit nach nerverhaltender radikaler Prostatektomie ist bislang noch ungeklärt. Mehrere verschiedene Ansätze zur Pathophysiologie der postoperativen erektilen Funktion werden derzeit diskutiert. In einer prospektiven Studie führten wir nächtliche penile Tumeszenz- und Rigiditätsmessungen (NPTR) in der Akutphase während der 1. Nacht nach Katheterentfernung nach nerverhaltender radikaler Prostatektomie durch, um die organisch-erektile Integrität zu beurteilen.
Bei 18 präoperativ sexuell aktiven Patienten mit lokal begrenztem Prostatakarzinom führten wir eine uni- oder bilaterale nerverhaltende Prostatektomie durch. Die präoperative erektile Funktion aller Patienten wurde mit dem „International Index of Erectile Function-“ (IIEF-)5-Fragebogen evaluiert. Am 14. postoperativen Tag wurde der transurethrale Katheter entfernt und es erfolgte eine NPTR-Messung in der darauf folgenden Nacht mittels Erektometer (Rigi-Scan®).
Alle Patienten wiesen einen präoperativen IIEF-Score >18 auf. Nach Katheterentfernung kam es bei 17 der 18 Patienten (95%) zu einer nächtlichen Rigiditätszunahme >70%, die >10 min anhielt. In einer Kontrollgruppe von 4 nicht nerverhaltend Operierten wies keiner der Patienten eine nächtliche Erektion in der 1. Nacht nach Katheterentfernung auf. Die NPTR-Messung in der Akutphase nach nerverhaltender radikaler Prostatektomie zeigte eine vorhandene erektile Funktion schon in der 1. Nacht nach Katheterentfernung.
Diese Ergebnisse sind von großer Bedeutung für die Wahl der weiteren Pharmakotherapie zur optimalen Wiederherstellung einer zufriedenstellenden Erektion und damit befriedigender Sexualfunktion. Im Falle einer vorliegenden Früherektion kann die supportive Medikation mit einem PDE-5-Inhibitor zur weiteren Organrehabilitation beitragen. Bei ausbleibenden spontanen nächtlichen Früherektionen sollten die penilen Injektionsverfahren erwogen werden.
Abstract
The time lapse before recovery of erectile function after nerve-sparing radical prostatectomy is still under debate. Several pathophysiologies are postulated for postoperative erectile function rehabilitation. In prospective studies we measured nocturnal penile tumescence (NPTR) in the acute phase during the first night after catheter removal subsequent to nerve-sparing radical prostatectomy to assess the neuronal organic erectile integrity.
Eighteen sexually active patients suffering from local prostate cancer underwent bilateral and unilateral nerve-sparing retropubic radical prostatectomy. All patients completed an IIEF-5 questionnaire concerning erectile function preoperatively. The transurethral catheter was removed 14 days after surgery, and nocturnal penile tumescence was measured with an erectometer (Rigi-Scan®) in each patient during the following night. None of these patients received any comedication interacting with erectile function.
The preoperative IIEF score was >18 in all patients. After catheter removal, 17 of 18 patients (95%) had nocturnal penile radial rigidity >70% that persisted for >10 min during one night. In a control of four patients without a nerve-sparing procedure, no nocturnal erections were recorded.
The measurement of NPTR in the acute phase after nerve-sparing radical prostatectomy showed retained erectile function even during the “first” night after catheter removal. Our findings are important for an appropriate choice of pharmacotherapy for optimal recovery of erectile function. In cases of early penile erections, the cavernous nerve had been well preserved during surgery providing good neuronal integrity, and PDE-5 inhibitors can support organic rehabilitation of the corpus cavernosum. In the absence of early penile erections, the neuronal integrity of the cavernous nerve is presumed to be impaired. In this case, additional injection therapy should be chosen to support recovery of spontaneous erectile function.
Literatur
Meulemann E, Mulders P (2003) Erectile function after radical prostatectomy: A review. Eur Urol 43: 95–102
Sperling H, Noldus J (2003) Prostatakarzinom und erektile Dysfunktion: Welche Therapie wann? Urologe A 42: 1351–1356
Altwein JE, Mohandessi B (2003) Prostata- und Samenblasentumoren. In: Jocham D, Miller K (Hrsg) Praxis der Urologie, Bd 2. Thieme, Stuttgart New York, S 174–224
Carrol PR (2003) Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. In: Hoffman RM, Hunt WC, Gilliland FD, Stephenson RA, Potosky AL (edn) Medicine Service, New Mexico VA Health Care System, Albuquerque, NM. Cancer 97: 1653-1662
Walsh PC, Marschke P, Ricker D, Burnett AL (2000) Patient reported urinary continence and sexual function after anatomical radical prostatectomy. Urology 55: 58–61
Noldus J, Michl U, Graefen M et al. (2002) Patient-reported sexual function after nerve-sparing retropubic radical prostatectomy. Eur Urol 42: 118–124
Michl U, Graefen M, Noldus J, Eggert T, Huland H (2003) Funktionelle Ergebnisse unterschiedlicher Operationstechniken der radikalen Prostatektomie. Urologe A 42: 1196–1202
Montorsi F, Maga T, Strambi LF et al. (2000) Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 20 (56): 906–911
Rabbani F, Stapleton A, Kattan M, Wheeler T, Scardino P (2000) Factors predicting recovery of erections after radikal prostatectomy. J Urol 164: 1929–1934
Montorsi F, Guazzoni G, Strambi LF et al. (1997) Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 158: 1408–1410
Moreland RB (1998) Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 10: 113–120
User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT (2003) Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 169: 1175–1179
Montorsi F (2003) Editorial Comment to: Meulemann E, Mulders P. Erectile function after radical prostatectomy: A review. Eur Urol 43: 101–102
Montorsi F, Salonia A, Zanoni M, Colombo R, Pompa P, Rigatti P (2001) Counselling the patient with prostate cancer about treatment-related erectile dysfunction. Curr Opin Urol 11: 611–617
Heathcote PS, Mactaggart PN, Boston RJ, James AN, Thompson LC, Nicol DL (1998) Health-related quality of life in Australian men remaining disease-free after radical prostatectomie. Med J Aust 168 (10): 477–478
Gontero P, Pretti G, Bagnasacco A, Kocjancic E. Frea B (2002) A prospective study on the optimal timing for intracavernous PGE rehabilitation following non nerve sparing radical prostatectomy. J Urol 167 [Suppl 4]: 147
Raina R, Agarwal A, Zippe CD (2002) Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potential return of erection. J Urol 167 [Suppl 4]: 279
Schwartz EJ, Wong P, Farmington CT, Graydon RJ (2002) Sildenafil preserves intracorporal smooth muscle content after bilateral nerve sparing redical retropubic prostatectomy. J Urol 167 [Suppl 4]: 279
Montorsi F, Salonia A, Barbieri L, Maga T, Zanoni M, Raber M (2002) The subsequent use of IC alprostadil and oral sildenafil is more efficacious than sildenafil alone in nerve sparing redical prostatectomy patients. J Urol 167 [Suppl 4]: 279
McCullough AR (2001) Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 28: 613–627
Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL (2004) Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 45: 123–133
Zippe CD, Kedia AW, Kedia K, Nelson DR, Agarwal A (1998) Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology 52: 963–966
Zagaja GP, Mhoon DA, Aikens JE, Brendler CB (2000) Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 56 (4): 631–634
Raina R, Nelson DR, Agarwal A, Lakin MM, Klein EA, Zippe CD (2002) Long term efficacy of sildenafil citrate following radical prostatectomy: 3-year follow-up. J Urol 167 [Suppl 4]: 279
Claro JD, Aboim JE, Maringolo M et al. (2001) Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study. Sao Paulo Med J 119: 135–137
Rodriguez Vela L, Gonzalvo Ibarra A, Bono Arino A, Benejam Gual J, Cuesta Presedo JM, Rioja Sanz LA (1997) Erectile dysfunction after radical prostatectomy etiopathology and treatment. Acta Urol Esp 21: 909–921
Levine L, McCullough A, Padma-Nathan H (2004) Longitudinal randomized placebo-controlled study of the return of nocturnal erections after nerve-sparing radical prostatectomy in men treated with nightly sildenafil citrate. J Urol 171 [Suppl]: 231–232
Jünemann KP (2003) Wie wirksam sind die PDE-5-Hemmstoffe? Urologe A 42: 553–558
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bannowsky, A., Schulze, H., van der Horst, C. et al. Erektionsstatus nach nervenerhaltender radikaler Prostatektomie. Urologe [A] 44, 521–526 (2005). https://doi.org/10.1007/s00120-005-0781-0
Issue Date:
DOI: https://doi.org/10.1007/s00120-005-0781-0